BOT 14.3% 40.0¢ botanix pharmaceuticals ltd

Ann: FDA Approves Sofdra, page-79

  1. 195 Posts.
    lightbulb Created with Sketch. 54
    A suburb (expected) outcome.

    with any luck the CR is oversubscribed by insto groups that require FDA. If that’s the case, this is a smart move by management. Get some more quality money in and fill the balance sheet ahead of aggressive commercialisation.

    you bewdy
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
40.0¢
Change
0.050(14.3%)
Mkt cap ! $724.0M
Open High Low Value Volume
35.5¢ 40.0¢ 35.5¢ $6.075M 15.87M

Buyers (Bids)

No. Vol. Price($)
5 287187 39.5¢
 

Sellers (Offers)

Price($) Vol. No.
40.0¢ 1920397 33
View Market Depth
Last trade - 16.10pm 30/08/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.